Emergence of polymyxin B resistance in a polymyxin B-susceptible KPC-producing Klebsiella pneumoniae causing bloodstream infection in a neutropenic patient during polymyxin B therapy
| Autor: | Laura Czekster Antochevis, Ana Cristina Gales, Jussara K. Palmeiro, Alexandre P. Zavascki, Raquel Girardello, Rafael A. Maciel, Cibele Massotti Magagnin |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
0301 basic medicine
Microbiology (medical) Neutropenia Adolescent Klebsiella pneumoniae medicine.drug_class Polymyxin 030106 microbiology Population Bacteremia Meropenem Microbiology Immunocompromised Host 03 medical and health sciences Drug Resistance Bacterial medicine Pulsed-field gel electrophoresis Humans education Polymyxin B education.field_of_study biology General Medicine biology.organism_classification Virology Klebsiella Infections Molecular Typing Infectious Diseases Amikacin Colistin Female medicine.drug |
| Zdroj: | Diagnostic Microbiology and Infectious Disease. 90:134-138 |
| ISSN: | 0732-8893 |
| DOI: | 10.1016/j.diagmicrobio.2017.10.006 |
| Popis: | The emergence of resistance to polymyxins in KPC-producing Klebsiella pneumoniae isolates has been a major clinical problem. This study evaluated the molecular mechanisms associated with polymyxin B (PMB) resistance that emerged in a previously PMB-susceptible KPC-2-producing K. pneumoniae during PMB therapy for a bloodstream infection in a neutropenic patient. The first isolate (PMB-susceptible) was obtained while the patient was receiving meropenem and other isolates were recovered from 2 sets of blood cultures in different dates while the patient was receiving PMB therapy (4 of 6 blood cultures bottles yielded isolates with full PMB resistance). The population analysis profile of the first isolate revealed the growth of resistant subpopulations with PFGE profile distinct from the parental isolate but undistinguishable from those obtained in subsequent days under PMB exposure. Resistant subpopulations were obtained from all parental PMB-susceptible and in one PMB-resistant isolate recovered from the patient. The molecular mechanism observed in the hetero-resistant subpopulations (IS1-like in mgrB-promoter region, increased rstB transcription with no mutation and non-identified mechanism) differed from those found in the PMB-resistant isolates, in which no mutation or transcriptional alterations were detected. This study showed that the mechanism of resistance to PMB that emerged during PMB therapy was not related to those observed in subpopulations selected in vitro from PMB-susceptible isolates recovered from the patient. The absence of mutations in the former isolates may be due to adaptive resistance occurred because of sub-optimal PMB levels as well as amikacin and meropenem used in combination. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect